William Wood
Family · Auburn, ALNPI 1235331521
Payments from drug & device makers
Across 123 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$467
- AbbVie$364
- Novo Nordisk$141
- GSK$119
- Exact Sciences$104
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$98
- plus $810 from 17 others
What the payments were for
- Food & beverage$2,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $467 |
| AbbVie | 22 | $364 |
| Novo Nordisk | 8 | $141 |
| GSK | 8 | $119 |
| Exact Sciences | 6 | $104 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $98 |
| Pfizer | 5 | $93 |
| Lilly USA, LLC | 6 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Corium, LLC | 7 | $81 |
| Idorsia Pharmaceuticals US Inc | 5 | $76 |
| Bayer | 4 | $66 |
| Abbott | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| Amgen | 3 | $43 |
| Radius Health, Inc. | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| Merck | 2 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Eisai Inc. | 1 | $14 |
| Akebia Therapeutics Inc | 1 | $14 |
How this compares
$2,102 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 101 | $103,220 |
| FarxigaDapagliflozin Propanediol | 88 | $57,076 |
| TrulicityDulaglutide | 26 | $26,435 |
| JardianceEmpagliflozin | 13 | $22,739 |
| MounjaroTirzepatide | 21 | $22,383 |
| RybelsusSemaglutide | 22 | $20,363 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $19,021 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $15,371 |
| JanuviaSitagliptin Phosphate | 16 | $11,567 |
| MyrbetriqMirabegron | 13 | $7,571 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 14 | $7,321 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $7,148 |
| Insulin Aspart Prot Mix 70-30Insulin Aspart Prot/Insuln Asp | 11 | $3,712 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $3,636 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $2,970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $141 | $123,583123 claims |
| AstraZenecaFarxiga | $467 | $57,07688 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $87 | $48,81847 claims |
| MerckJanuvia | $27 | $11,56716 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $7,57113 claims |
| AbbVieSynthroid | $364 | $1,81717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.
Other family in Auburn
- Molly ReevesAuburn$158K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.